Daniel Barber | executive |
Ernie Toth | executive |
Roanna Clarissa Ruiz | analyst |
Sherry Korczynski | executive |
Carl Kraus | executive |
David Amsellem | analyst |
François Brisebois | analyst |
Raghuram Selvaraju | analyst |
Stephen Wargacki | executive |
Thomas Flaten | analyst |
Jason Butler | analyst |
Gary Nachman | analyst |
James Molloy | analyst |
Good morning, and welcome to the Aquestive Therapeutics Second Quarter 2024 Conference Call. [Operator Instructions]
As a reminder, this call will be recorded. I would now like to introduce your host for today's conference call, Bennett Watson of ICR West Investor Relations.
You may begin.